Vivid iq vs Irregular Rhythm Notification Feature (IRNF)

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 65/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.

Vivid iq

by GE HealthCare

Irregular Rhythm Notification Feature (IRNF)

by Apple

AI Verdict

Tool A is a professional, portable ultrasound system designed for detailed cardiovascular diagnostics by clinicians, offering advanced imaging and quantification. In contrast, Tool B is a consumer-facing feature on the Apple Watch that screens for irregular heart rhythms suggestive of AFib, empowering users with proactive health insights. While both utilize AI in cardiology, their distinct deployment, target users, and primary functions make them complementary rather than directly comparable.

Choose Vivid iq if…

Choose Vivid iq if your clinical practice requires a portable, high-resolution cardiovascular ultrasound system for detailed diagnostic imaging and advanced quantification. It is ideal for medical professionals needing precise 2D and 4D imaging at the point of care in specialties like cardiology, emergency medicine, or radiology. This tool is best suited for comprehensive anatomical and functional assessments by trained clinicians.

View Vivid iq →

Choose Irregular Rhythm Notification Feature (IRNF) if…

Choose the Irregular Rhythm Notification Feature if you are a consumer seeking a convenient, over-the-counter solution for proactive heart rhythm screening. This feature is designed for individuals who want to be notified of potential irregular heart rhythms suggestive of AFib, enabling them to share this information with their physician for further evaluation. It serves as a personal monitoring tool to empower early discussions about heart health.

View Irregular Rhythm Notification Feature (IRNF) →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature	Vivid iq	Irregular Rhythm Notification Feature (IRNF)
Pricing	Starts at $7,650 (refurbished) to $38,388 (new). leasing options start at $547.82/month or $999/month.	Included with apple watch purchase
Deployment	On-premise	Device-based (Apple Watch), integrated with the iPhone Health app.
BAA Available	Yes AI-estimated	Unknown
FDA Status	Cleared AI-estimated	Yes AI-estimated
HIPAA	Yes AI-estimated	Unknown

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

Irregular Rhythm Notification Feature (IRNF)

Tool B (IRNF) is designed for over-the-counter use by general consumers, integrated into the familiar Apple Watch and iPhone ecosystem with an intuitive onboarding process and educational materials. In contrast, Tool A (Vivid iq) is a specialized, ultra-portable cardiovascular ultrasound system, requiring trained medical professionals for operation and interpretation.

Clinical Value

Vivid iq

Tool A (Vivid iq) offers direct diagnostic capabilities through high-resolution 2D and 4D imaging with advanced quantification tools, enabling efficient and accurate diagnostics across various medical specialties. Tool B (IRNF) serves as a screening tool, notifying users of irregular heart rhythms suggestive of AFib to prompt further medical consultation, rather than providing a definitive diagnosis.

Pricing & Value

Irregular Rhythm Notification Feature (IRNF)

Tool B (IRNF) is included with the purchase of an Apple Watch, offering significant value as a health screening feature without additional cost beyond the consumer device. Tool A (Vivid iq) is a specialized medical device with a substantial price point, previously observed between $12,999.00 and $32,200, representing a considerable capital investment for healthcare facilities.

Enterprise Readiness

Vivid iq

Tool A (Vivid iq), from GE HealthCare, is designed for enterprise healthcare environments, offering a Business Associate Agreement (BAA) and direct HIPAA compliance for seamless integration into clinical workflows. Tool B (IRNF), while securing data, explicitly states that Apple does not offer a BAA for the feature, placing HIPAA compliance responsibility on the covered entity, which complicates its direct enterprise integration.

Innovation

Irregular Rhythm Notification Feature (IRNF)

While Tool A (Vivid iq) innovates by bringing AI to advanced diagnostic ultrasound in a portable format, Tool B (IRNF) represents a more disruptive innovation. It democratizes FDA-cleared, machine learning-based cardiac rhythm screening for AFib through a widely adopted consumer wearable, empowering a broad population with proactive health insights.

Support & Docs

Tie

Both tools offer robust support and documentation tailored to their respective user bases. Tool A (Vivid iq), as a professional medical device, provides comprehensive service manuals, technical publications, and professional support for clinicians and IT staff. Tool B (IRNF) benefits from Apple's extensive consumer support ecosystem, including detailed online articles, user guides, and an onboarding process with educational materials.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature	Vivid iq	Irregular Rhythm Notification Feature (IRNF)
Name	Vivid iq	Irregular Rhythm Notification Feature (IRNF)
Company	GE Medical Systems Ultrasound and Primary Care Diagnostics	Apple
Primary Function	AI-powered, ultra-portable cardiovascular ultrasound system offering high-resolution 2D and 4D imaging with advanced quantification tools for efficient and accurate diagnostics.	Screens for irregular heart rhythms suggestive of AFib, empowering users with notifications to facilitate discussions with their physicians.
Categories	Cardiology AI, Radiology & Imaging AI	Cardiology AI, Wearables & Remote Monitoring (RPM)
Specialties	Cardiology, Emergency Medicine, Radiology	Cardiology, Family Medicine, Internal Medicine

Videos

Demos, reviews, and walkthroughs featuring Vivid iq and Irregular Rhythm Notification Feature (IRNF).

Loading videos…

Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

How can physicians best integrate patient-shared data from the Irregular Rhythm Notification Feature into their clinical workflow and EHR, considering the data originates from a consumer device?

Patients can export and share their health data, including IRNF notifications, from the Apple Health app with their physicians. This data typically requires manual review and documentation within the EHR, serving as a prompt for further diagnostic evaluation rather than a definitive diagnosis.

What are the reported sensitivity and specificity of the Irregular Rhythm Notification Feature for detecting AFib, and how should physicians interpret these notifications in the context of a patient's overall clinical picture?

The Irregular Rhythm Notification Feature has demonstrated high specificity (99.6%) in classifying sinus rhythm and good sensitivity (98.3%) in classifying AFib in classifiable recordings, though some studies show lower sensitivity in real-world use. Physicians should consider these notifications as a screening tool that warrants further clinical evaluation, such as a diagnostic ECG, especially since it is not intended to replace traditional diagnostic methods.

How do the Vivid iq's advanced 2D and 4D imaging with AI-powered quantification tools enhance diagnostic accuracy and patient management for cardiovascular and emergency medicine specialists?

The Vivid iq provides high-resolution 2D and 4D imaging with advanced quantification tools, including AI algorithms that reduce manual steps and improve workflow efficiency. This enables more precise and efficient diagnosis of complex cardiovascular conditions, aiding in treatment planning and improving patient outcomes across various clinical settings.

What is the expected learning curve for clinicians to effectively utilize the Vivid iq's AI-powered features and advanced quantification, and what level of ongoing support and training does GE HealthCare offer?

While the Vivid iq features an intuitive touch interface, mastering all advanced features and optimizing image quality may require some training and experience. GE HealthCare offers comprehensive training programs, including virtual face-to-face sessions with clinical application experts and online content, to help clinicians become proficient and maximize equipment use.

What considerations should a multi-site healthcare organization address when planning a rollout of the Vivid iq, particularly regarding standardization, integration, and data management across different facilities?

Multi-site rollouts of the Vivid iq benefit from standardized imaging protocols, consistent data acquisition, and seamless integration with centralized PACS/EHR systems. GE HealthCare can provide guidance and support for enterprise-level solutions to ensure consistent deployment, data management, and operational efficiency across various locations.

What is the typical time-to-value for a clinic or department after implementing the Vivid iq, considering the impact on diagnostic efficiency and patient throughput?

The Vivid iq's portability, AI-driven workflow, and advanced features can lead to a relatively quick time-to-value by immediately enhancing diagnostic capabilities and workflow efficiency. Automated processes and high-resolution imaging contribute to faster patient assessments and improved diagnostic confidence, thereby increasing patient throughput.

More Comparisons

Assert-IQ vs Rapid Enterprise Platform

AISAP Cardio vs Rapid Enterprise Platform

AngioWaveNet vs Rapid Enterprise Platform

CorVista System with PH Add-On vs Rapid Enterprise Platform

More matchups featuring Vivid iq or Irregular Rhythm Notification Feature (IRNF)

Backers

Who funded each tool's parent company.

Irregular Rhythm Notification Feature (IRNF)

Transformer VC